Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Net Income 2015–2025
Crispr Therapeutics AG annual/quarterly net income history and growth rate from 2015 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Crispr Therapeutics AG net income for the quarter ending March 31, 2026 was -122.9 M, a 9.61% decrease year-over-year.
- Crispr Therapeutics AG net income for the twelve months ending March 31, 2026 was -573.9 M, a 30.11% increase year-over-year.
- Crispr Therapeutics AG annual net income for 2025 was -581.6 M, a 58.80% increase from 2024.
- Crispr Therapeutics AG annual net income for 2024 was -366.3 M, a 138.43% increase from 2023.
- Crispr Therapeutics AG annual net income for 2023 was -153.6 M, a 76.37% decrease from 2022.
- Crispr Therapeutics AG annual net income for 2022 was -650.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crispr Therapeutics AG Net Income — FAQ
Crispr Therapeutics AG (CRSP) net income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Crispr Therapeutics AG's net income?
Crispr Therapeutics AG (CRSP) reported net income of -$582M for fiscal 2025.
Where can I see CRSP's net income history?
The chart and table above show Crispr Therapeutics AG's net income by year and by quarter, including the growth rate.